XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS’ DEFICIT
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 6 – STOCKHOLDERS’ DEFICIT

 

The Company is authorized to issue 295,000,000 authorized shares of common stock with a par value of $0.001 as of December 31, 2023 and 2022. On November 4, 2022, the Company reduced its authorized shares of common stock, par value $0.001 per share, from 1,000,000,000 shares to 295,000,000 shares. On June 3, 2022, the Board authorized the execution of a reverse split of the issued and outstanding shares of the Corporation’s common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000) . The reverse split was approved by FINRA on September 2, 2022.

 

The Company had 109,138,049 and 107,582,614 issued and outstanding shares of common stock as of December 31, 2023 and 2022, respectively.

 

The Company also has 500,000 authorized shares of preferred stock with a par value of $0.001, which the Company has designated as Series A Preferred Stock. On November 4, 2022, the Company reduced its authorized shares of preferred stock from 50,000,000 shares to 500,000 shares. Each share of Series A Preferred Stock is convertible, at any time, at the option of the holder at a rate of 30% of the market price of the stock based on a 10 day average trading price of the common stock. In addition, the holders of the Series A Preferred have voting rights equal to 20 votes for each Preferred share held. As of December 31, 2023 and 2022, 500,000 and 500,000 shares of Series A Preferred stock are issued and outstanding, respectively.

 

On November 4, 2022, the Company filed Certificates of Withdrawal in Nevada to withdraw the Certificates of Designation for Series B Preferred Stock and Series C Preferred Stock. Following the filings, the only designated and outstanding shares of preferred stock are the Company’s Series A Preferred Stock.

 

During the year ended December 31, 2023, the Company issued 1,555,435 shares of common stock for cash proceeds of $253,236, of which $37,044 had been received in a prior period.